CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)
Authors
A Harrer
A Laroni
+46 more
A Posevitz-Fejfar
AM Arvin
Anita Posevitz-Fejfar
B Grutzke
Berit Grützke
Catharina C. Gross
CH Polman
CH Polman
DH Miller
G Bloomgren
G Defer
Heinz Wiendl
J Killestein
JA Cohen
JF Kurtzke
L Gorelik
L Kappos
Lucienne Kirstein
Luisa Klotz
M Cohen
M Kaufman
M Mehling
M Niino
M Sester
M Sospedra
Maria Eveslage
ME Ricklin
MH Graler
Michael Deppe
N Schwab
N Schwab
Nicholas Schwab
O Stuve
P Wipfler
PW O’Connor
RJ Fox
Sven G. Meuth
T Plavina
T Rispens
T Schneider-Hohendorf
T Widmann
TH Pham
Tilman Schneider-Hohendorf
VG Jokubaitis
WA Sheremata
Z Calic
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs12883-015-...
Last time updated on 05/06/2019